Pennsylvania Attorney General Sues Insulin Manufacturers and PBMs Over Pricing

Harrisburg Lancaster Lebanon York, PA, October 15, 2026 —

Pennsylvania Attorney General Dave Sunday has filed a lawsuit in Commonwealth Court accusing major insulin manufacturers and pharmacy benefit managers, or PBMs, of artificially inflating insulin prices through what the complaint describes as a “pricing scheme.” The alleged conduct potentially harmed millions of Pennsylvanians, according to the information provided about the case.

The lawsuit places the companies’ insulin pricing practices at the center of a legal challenge by the state. The accusations are allegations; the available information does not say that a court has made findings or reached a decision on them.

The names of the manufacturers and PBMs targeted by the lawsuit were not provided. The date the case was filed, the specific practices alleged, and the evidence cited in the complaint were also not included in the summary. It does not state what legal remedies Sunday is seeking or provide responses from the companies.

The information available does not detail how the alleged pricing scheme operated or explain how the potential harm to Pennsylvanians was measured. It also does not specify whether the lawsuit includes claims beyond the accusation that the companies artificially inflated insulin prices.

Further details about the complaint, the defendants’ positions and the next steps in Commonwealth Court were not provided. For now, the reported development is the filing itself and the attorney general’s allegation that the defendants’ pricing conduct may have affected millions of residents.

Story summarized from the original created by Whitney Downard, Pennsylvania Capital-Star on www.witf.org, see more information here.

Media gallery